Affiliation:
1. Department of Accounting and Commercial Law, Hanken School of Economics, Helsinki; and Faculty of Law, University of Turku, Finland
2. Faculty of Law, University of Lapland, Rovaniemi, Finland
Abstract
The COVID-19 pandemic has shown how equitable vaccine distribution still remains unaccomplished. While access to COVID-19 vaccines has been efficient in the EU, the Latin American situation is very different. For example, the Andean Community reports that, as of December 2022, 83% of the population had received at least the first dose of the vaccine while only 43% had received the third dose ( http://www.orasconhu.org ). Motivated by the challenges and successes endured by countries in the Andean Community vis-à-vis the EU during COVID-19 vaccine roll-outs, we analyse key legal, policy and management factors affecting vaccine equity. We are especially critical of the strategy followed in the Andean Community, namely, of increasing dependency on imports and donations instead of harnessing other more effective policies. We highlight the specific role of the factors identified in achieving coherent policy strategies and propose recommendations to promote equitable vaccine distribution in the Andean Community, and beyond.
Subject
General Arts and Humanities
Reference69 articles.
1. Artecona R., Plank-Brumback R. 2016. Access to medicines and incentives for innovation: the balance struck in the Trans-Pacific Partnership (TPP) on intellectual property (patent and data exclusivity) protection for pharmaceutical products, Studies and Perspectives Series – Washington, D.C. – No. 16 (ECLAC).
2. Global COVID-19 vaccine inequity: The scope, the impact, and the challenges
3. Development and technology transfer of Haemophilus influenzae type b conjugate vaccines for developing countries
4. Governance for the Conservation of Nature